<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03902925</url>
  </required_header>
  <id_info>
    <org_study_id>ST anesthesia for PPV</org_study_id>
    <nct_id>NCT03902925</nct_id>
  </id_info>
  <brief_title>Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia</brief_title>
  <official_title>Pain During Pars Plana Vitrectomy Comparing Peribulbar Anesthesia Versus Sub-tenon Injection Plus Topical Jelly Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitreoretinal surgery has evolved to less invasive procedures, and it is used to treat a wide
      range of diseases. So anesthesia for vitreoretinal procedures has evolved, promoting adequate
      analgesia while reducing risks to the patient. In the present study two types of procedures
      for anesthesia during vitreoretinal surgery are evaluated regarding the pain referred by the
      patient during the whole procedure: peribulbar anesthesia versus sub-tenon injection plus
      topical jelly anesthesia. Through the comparative analysis of the pain scale of the two
      groups it is expected that the two modalities present the same anesthetic efficacy, showing
      that the methods used may be equivalent.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">October 31, 2019</completion_date>
  <primary_completion_date type="Actual">August 31, 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score</measure>
    <time_frame>Once 30 minutes after the end of the vitrectomy surgery</time_frame>
    <description>Pain score referred by the patient measured with a Visual Analogue Scale (VAS). The VAS consists of ruler with 100 cm in length and scale from 0 to 100, where the numbers of this one are visible only in the side of the examiner. It is constructed from a metal ruler with a total length of one meter, supported by two transparent acrylic side supports and a sliding and movable metal weight on the metallic part of the ruler.
Before the measurement of pain, the examiner will explain to the patients the functioning of the VAS. Each patient will be encouraged to pass the marker along the scale, with the help of the examiner. It will be made clear to him that point &quot;0&quot; is the point of the scale which represented &quot;no pain&quot;, what is considered the better outcome, and point &quot;100&quot; corresponded to the most intense pain he could feel. The patient will be asked about: Intraoperative pain - the intensity of pain throughout the procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>Once At the end of vitrectomy surgery</time_frame>
    <description>Surgical complications referred by the surgeon during vitrectomy</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Duration of surgery</measure>
    <time_frame>Once At the end of vitrectomy surgery</time_frame>
    <description>Duration of vitrectomy in minutes</description>
  </other_outcome>
  <other_outcome>
    <measure>Anesthetic medications</measure>
    <time_frame>Once during the vitrectomy surgery</time_frame>
    <description>Other anesthetic medication for controlling pain administered during the study</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Retinal Disease</condition>
  <condition>Diabetic Retinopathy</condition>
  <condition>Maculopathy</condition>
  <arm_group>
    <arm_group_label>Group 1- Sub-tenon plus lidocaine jelly</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients are going to be submitted to lidocaine 2% jelly topical anesthesia for 5 minutes then to sub-tenon injection of 2-4 ml of ropivacaine 10% previous to 23 G pars plana vitrectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2- peribulbar</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients are going to be submitted to peribulbar injection of 4-6 ml of ropivacaine 10% previous to 23 G pars plana vitrectomy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Topical lidocaine 2% jelly plus sub-tenon ropivacaine 10% injection</intervention_name>
    <description>Lidocaine 2% jelly applied to conjunctival fornices for 5 minutes then injection of 2-4 ml of ropivacaine 10% in the sub-tenon space with a blunt cannula through a temporal inferior incision</description>
    <arm_group_label>Group 1- Sub-tenon plus lidocaine jelly</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Peribulbar injection</intervention_name>
    <description>Peribulbar injection of 4-6 ml of ropivacaine 10%</description>
    <arm_group_label>Group 2- peribulbar</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients that have the diagnosis of epiretinal membrane, macular hole, complication of
             diabetic retinopathy such as vitreous hemorrhage or traction retinal detachment or
             other vitreomacular diseases that require treatment by pars plana vitrectomy.

        Exclusion Criteria:

          -  Previous pars plana vitrectomy in the studied eye.

          -  Previous scleral buckle surgery

          -  Uncontrolled arterial hypertension

          -  Any ocular surgery performed in the studied eye in the previous three months

          -  Medical or psychological condition that preclude study adherence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jefferson AS Ribeiro, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Medicine - Clinical Hospital</name>
      <address>
        <city>Ribeirao Preto</city>
        <state>SP</state>
        <zip>14049-900</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Tang S, Lai P, Lai M, Zou Y, Li J, Li S. Topical anesthesia in transconjunctival sutureless 25-gauge vitrectomy for macular-based disorders. Ophthalmologica. 2007;221(1):65-8.</citation>
    <PMID>17183205</PMID>
  </reference>
  <reference>
    <citation>Stevens JD, Foss AJ, Hamilton AM. No-needle one-quadrant sub-tenon anaesthesia for panretinal photocoagulation. Eye (Lond). 1993;7 ( Pt 6):768-71.</citation>
    <PMID>8119430</PMID>
  </reference>
  <reference>
    <citation>Spaeth G. Ophthalmic Surgery, Principles and Practice. Third Edition. Saunders, Philadelphia, 2003.</citation>
  </reference>
  <reference>
    <citation>Sousa FAEF, Silva JA. Avaliação e mensuração da dor em contextos clínicos e de pesquisa. Rev. Dor, 2004;5(4):408-429.</citation>
  </reference>
  <reference>
    <citation>Roman SJ, Chong Sit DA, Boureau CM, Auclin FX, Ullern MM. Sub-Tenon's anaesthesia: an efficient and safe technique. Br J Ophthalmol. 1997 Aug;81(8):673-6.</citation>
    <PMID>9349156</PMID>
  </reference>
  <reference>
    <citation>Revill SI, Robinson JO, Rosen M, Hogg MI. The reliability of a linear analogue for evaluating pain. Anaesthesia. 1976 Nov;31(9):1191-8.</citation>
    <PMID>1015603</PMID>
  </reference>
  <reference>
    <citation>Rao GP, Wong D, Groenewald C, McGalliard JN, Jones A, Ridges PJ. Local anaesthesia for vitreoretinal surgery: a case-control study of 200 cases. Eye (Lond). 1998;12 ( Pt 3a):407-11.</citation>
    <PMID>9775241</PMID>
  </reference>
  <results_reference>
    <citation>Theocharis IP, Alexandridou A, Tomic Z. A two-year prospective study comparing lidocaine 2% jelly versus peribulbar anaesthesia for 25G and 23G sutureless vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1253-8. Epub 2007 Mar 7.</citation>
    <PMID>17342504</PMID>
  </results_reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>April 2, 2019</study_first_submitted>
  <study_first_submitted_qc>April 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>October 31, 2019</last_update_submitted>
  <last_update_submitted_qc>October 31, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Jefferson Augusto Santana Ribeiro</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>vitrectomy</keyword>
  <keyword>anesthesia</keyword>
  <keyword>retinal disease</keyword>
  <keyword>Pain</keyword>
  <keyword>diabetic retinopathy</keyword>
  <keyword>maculopathy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
    <mesh_term>Macular Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>We intend to have patient data stored but not individually available for researches at other sites in order to preserve anonymity of the patient.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

